FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1351 November 1, 2001 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In their Clinical Practice article (June 14 issue), Lee and Boucher review the use of noninvasive tests in patients with stable coronary artery disease.¹ However, the authors do not comment on electron-beam computed tomography as a noninvasive diagnostic technique.

Electron-beam computed tomography is a method of cross-sectional imaging with high spatial and temporal resolution, permitting the assessment of coronary calcifications as well as the visualization of the lumina of coronary arteries. In recent years, many studies have investigated the clinical value of this type of computed tomography in patients with symptomatic or asymptomatic coronary artery disease. As . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Yao, M., Kargman, S., Lam, E. C., Kelly, C. R., Zheng, Y., Luk, P., Kwong, E., Evans, J. F., Wolfe, M. M. (2003). Inhibition of Cyclooxygenase-2 by Rofecoxib Attenuates the Growth and Metastatic Potential of Colorectal Carcinoma in Mice. Cancer Res. 63: 586-592 [Abstract] [Full Text]